Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “car-t”

10 pharma patents match "car-t" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 10
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 10 pharmaceutical patents matching "car-t" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

10 results for “car-t” · 30,257 patents in full index Clear search

  1. US 12421302

    CAR-t cells and autoimmune diseases

    The Regents of the University of California · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12036243

    BCMA CAR-T cells with enhanced activities

    Allogene Therapeutics, Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  3. US 11987628

    Methods and compositions for modulating CAR-T activity

    Sana Biotechnology, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  4. US 11965022

    Methods and compositions for modulating CAR-T activity

    Sana Biotechnology, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  5. US 11802157

    Methods and compositions for modulating CAR-T activity

    Sana Biotechnology, Inc. · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  6. US 11472884

    Humanized BCMA antibody and BCMA-CAR-T cells

    Caribou Biosciences, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  7. US 11299549

    Humanized BCMA antibody and BCMA-CAR-T cells

    Caribou Biosciences, Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted
  8. US 11021542

    Humanized BCMA antibody and BCMA-CAR-T cells

    Caribou Biosciences, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  9. US 10927182

    Humanized BCMA antibody and BCMA-CAR-T cells

    Caribou Biosciences, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  10. CA 3098014

    CELLULES CAR-T ANTI-BCMA POUR DEPLETION DE CELLULES PLASMATIQUES

    CRISPR THERAPEUTICS AG [CH] · Granted Oct 31, 2019 · Expires Oct 26, 2039

    granted